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Summary.-Eight British adults with tumours histologically and cytochemically
identical to African Burkitt's lymphoma are described. In each case there was
an acute clinical onset and similar tumour distribution, with involvement of the
intra-abdominal organs, bone marrow and central nervous system. Jaw tumours
were only present in 3 cases, and were never gross. Four patients presented as
acute leukaemia. Combination chemotherapy and cranial irradiation were used
to eradicate disease, but complete remissions were obtained in only 3 patients, and
survival of over 1 year in only 2. The remainder died with disease present, less
than 5 months from diagnosis.
SINCE the recognition ofthe distinctive
clinicopathological syndrome of African
Burkitt's lymphoma (Burkitt, 1958;
O'Connor, 1961) sporadic cases have
been reported from most countries, and
a series of over 100 children and adoles-
cents has been collected in the United
States (Levine et al., 1975).
It is known, however, that the clinical
features of the African disease depend
on the age at presentation (Burkitt,
1970) and the incidence of the tumour
within different tribes (Burkitt and
Wright, 1966).
A retrospective study of 9 British
children (mean age 7-3 years) showed
many similarities in tumour distribution
to Africans (Wright, 1966) but more
recent reports of American cases have
shown marked differences in the frequency
of jaw tumours, intra-abdominal and
central nervous system (CNS) involve-
ment (Levine et at., 1975) a poorer
response to cytotoxic therapy (Ziegler,
1972; Arseneau et al., 1975), and an
inability to demonstrate EBV consistently
within the tumours (Andersson et al.,
1976). There is a much higher frequency
of bone marrow infiltration in non-
African patients (Levine et al., 1975)
and presentation as acute non-myelo-
genous leukaemia has been reported in
6 cases (mean age 11*7 years) from France
(Flandrin et al., 1975).
Because of these marked age-related
and geographical differences in the pre-
sentation and behaviour of Burkitt's
lymphoma, we think it worthwhile to
describe the findings of what we believe
to be the first reported series of British
adults (15 years and over) with Burkitt's
lymphoma, with special reference to the
clinical features and response to combina-
tion cytotoxic therapy, cranial irradiation
and maintenance therapy similar to that
used for common ALL.
PATIENTS AND METHODS
The patients, 6 male and 2 female, mean
age 24-5 years, were admittedduring 1973-74,
and comprise less than 5% of cases referred
for management of haematopoietic or lym-
phoreticular malignancies during that period.
No patient had received specific therapy
prior to admission. One patient (Case 5)
had been to a tropical area, visiting central
S. America 30 years previously. ThereBRITISH BURKITT S LYMPHOMA4
were no other relevant points in the social and
family histories, and no other serious illnesses.
Biopsy material was available in 5 cases,
and suitable for electron microscopy (EM)
in 3. Touch preparations of tumour from
2 cases, malignant pleural and ascitic fluid
from 1, and bone marrow from all cases
were stained with May-Gruinwald-Giemsa
(MGG), periodic acid-Schiff, Sudan black,
oil red 0, pyronin, and stains for acid
phosphatase and c-naphthyl esterase by
standard techniques. Tumour cells were
examined by EM after fixation in glutaral-
dehyde and post-fixation in osmium tetroxide
and uranyl acetate. Cerebrospinal fluid
(CSF) was examined after centrifugation in
a cytocentrifuge by MGG and cytochemical
stains.
The diagnosis of Burkitt's lymphoma
was established in each case, using the
morphological, ultrastructural and cytochem-
ical criteria defined by the W.H.O. (Berard et
al., 1969). Routine investigations on all
patients included a full blood count, liver
function tests and estimation of blood urea,
electrolytes, uric acid, immunoglobulins and
antibodies to EBV. Radiography of the
chest and other organs was carried out
where clinically indicated, to assess tumour
distribution.
CLINICAL FEATURES
The disease was characterized by an
acute onset, with a history of usually
less than 8 weeks general ill-health, some
weight loss and occasional night sweats.
Pain in the jaw occurred in 4 cases
and paraesthesiae of the lips and chin
in 4. Only 2 patients had sought a
dental opinion. Abdominal pain or a
change in bowel habit occurred in 5
cases, exploratory laparotomy being per-
formed in 2 for an acute abdomen. Two
patients complained of bruising (Cases
5, 8), one of a swelling on the chest wall
(Case 4) and one of parotid enlargement
(Case 7).
The distribution of tumour at presen-
tation was similar in all patients. Intra-
abdominal involvement (7 cases) included
infiltration of the terminal ileum, mesen-
teric and retroperitoneal lymph nodes,
liver and kidneys. The spleen was only
palpable in 1 patient and there were mod-
erately enlarged peripheral lymph nodes in
3. Cranial nerve (c.n.) lesions were demon-
strated in 4 patients, involving c.n.V
alone in 3 and c.n. III, V, VI and VII in
1. Small jaw tumours were palpable in
2 cases and demonstrated radiologically
in 1 other. Small pleural effusions were
noted in 4 cases. Bone marrow infiltra-
tion by tumour cells was found in 6
cases less than 1000 of the nucleated
cell count in 2 cases, but greater than
7000 in the remainder, who also exhibited
a leukaemic blood picture (Table I).
Moderate anaemia was present in 6 cases
and thrombocytopenia (platelets < 50 x
109/1) in 3. All patients showed abnor-
malities of liver function tests, particu-
larly, raised levels of serum aspartate
TABLE I.-Clinical Features at Presentation of Burkitt's Lymphoma
(Disease present +; absent 0)
Case
Age, Sex
Jaw
Intra-abdominal
CNS
Bone marrow
Circulating tumour cells,
109/1
Alk phos., iu/l
SGOT, iu/l
HBD, iu/l
Uric acid, mm
EBV titres, 1:
20 M
nil
36
177
3000
0 77
32
2 3 4 5 6
16M A 36 M 28 M 43 M 21 M
o 0 0
0 + +
O 0 + +
i -n n 0
nlit nil nil 0-77 57-8
640
202
650
0 5
128
53
38
not done
0 43
64
1400
141
4000
0 47
32
112
44
1780
0 77
16
150
110
3000
3-78
16
7
17 F
0
+
0
8
15 F
0
+
0
0-11 1-5
58
24
not done
0 47
512
105
56
114
0 37
128
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transaminase (SGOT), alkaline phospha-
tase (Alk. phos.) and hydroxybutyric acid
(HBD). Uric dehydrogenase was increased
in 7 patients and associated in Case 6
with urate nephropathy and acute renal
failure, requiring peritoneal dialysis.
There were no significant changes in Ig
levels, and all patients had low titres
of IgG antibodies to EBV. Relevant
haematological and biochemical data are
summarized in Table I.
TREATMENT AND CLINICAL COURSE
All patients received allopurinol for
at least 24 h before commencing com-
bination cytotoxic therapy, which for
7 patients consisted of courses of adria-
mycin, vincristine, prednisolone and L-
asparaginase (Case 6 at reduced dosage),
Case 2 receiving courses of cyclophos-
phamide (CTX), vincristine and pred-
nisolone.
There were 2 early deaths due to
septicaemia and thrombocytopenia, but
3 partial and 3 apparently complete
remissions were obtained. Lumbar punc-
ture on these 6 cases immediately before
changing induction or starting main-
tenance therapy of CTX, methotrexate
(MTX) and 6-mercaptopurine (6-MP), re-
vealed tumour cells in the CSF of5. Thera-
peutic CNS treatment in these 5 cases,
and prophylaxis in 1, consisted of irradia-
tion to the whole cranium and intrathecal
(i.t.) injections of MTX followed by i.t.
cytosine arabinoside if infiltration per-
sisted or recurred. This regime caused
a rapid but only transient clearing of
cells from the CSF in all but Cases 7
and 8. The typical clinical course was
resistance to further chemotherapy, with
regrowth and spread of tumour, return
of malignant cells to the CSF and death
5 months or less from diagnosis. The
distribution of tumour and length of
survival are shown in Table II. Of the
2 " long-term " survivors, 1 had a bone
marrow relapse after 8 months, success-
fully treated with the same induction
therapy, but died in a second relapse
TABLE II.-Organ Involvement during the
Course of the Disease, and Sujrvival
Case
Jaw
Intira-ab(lominal
CNS
Bone marrow
Survival (months)
1 2 3 4 5 6
+ O + + O O
+ + O + + +
7 8
0 0
I I~~~~~~~~~~~~~-
+ +±r 2+ + 5 + + + +
2 5 1 3 5 0 5 >36 14
at 14 months, and 1 patient remains
alive at 36 months, but with tumour cells
in the CSF.
DISCUSSION
The pathological diagnosis of Burkitt's
lymphoma is still based on a combination
ofmorphological, ultrastructural and cyto-
chemical features, for although both
African and non-endemic tumours have
been shown to be proliferations of B
lymphocytes (Fialkow et al., 1973; Mann
et al., 1976) this feature does not clearly
differentiate the tumour from many other
lymphoid neoplasias. The particular value
of Romanowsky-stained tissue imprints
in establishing an accurate diagnosis
has been stressed previously (Wright,
1967; Levine et al., 1975) and confirmed
in this study.
The association of EBV and holo-
endemic malaria with the African tumours
is well known, but the role of EBV in
non-endemic cases is less well defined
(Andersson et al., 1976). Serum IgG
antibodies to EBV were present in all
our patients, but material suitable for
demonstration of viral genomes within
the cells was unfortunately not available.
Tumour distribution is similar to that
reported in Africans from areas of low
tumour incidence (Burkitt and Wright,
1966) and in American cases (Levine et
al., 1975), intra-abdominal disease being
more prominent than jaw tumours. Seven
patients (88%) had bone marrow in-
filtrated by malignant cells at some
stage, compared to 16%0 of African
cases (Bluming, Ziegler and Carbone,
1972) and 310% of American (Banks et
al., 1975). Four patients (50%0) pre-
sented as an acute leukaemia, withBRITISH BURKITT S LYMPHOMA 487
clinical features attributable more to
a primary haematopoietic disorder, than
to terminal dissemination of a lymphoid
tumour. This manifestation of Burkitt's
lymphoma is rare (Bluming et al., 1972;
Flandrin et al., 1975). Presentation with
intra-abdominal, CNS, and bone marrow
disease, with increased levels of serum
enzymes, are features associated in Ameri-
can cases with a median survival of less
than 2 months (Arseneau et al., 1975),
but 4400 of similarly staged African
cases survive for 18 months or longer
when treated with CTX alone (Ziegler,
1972). Our experience with combination
chemotherapy (7 cases receiving adria-
mycin, vincristine, prenisolone and L-
asparaginase), cranial irradiation and i.t.
MTX and Ara-C, is similar to results
in American cases, in that although
3 apparently complete remissions were
achieved 6 cases relapsed, with return
or spread of tumour resistant to further
chemotherapy, and subsequently died
5 months or less from initial diagnosis.
Two patients in remission (both female)
received maintenance therapy of CTX,
MTX and 6-MP. One relapsed after
8 months, was successfully treated with
the same combination chemotherapy, but
relapsed again and died 14 months from
diagnosis. The second patient remains
alive at 36 months, but with CSF involve-
ment. Others have also shown that
females survive longer than males (Levine
et al., 1975).
It is hoped that a greater awareness
of the occurrence of Burkitt's lymphoma
in British adults, especially the combina-
tion of intra-abdominal disease with c.n.
lesions, will lead to further insights
into the pathogenesis of the disorder and
better therapeutic measures.
We wish to thank Dr M. E. J. Beard
of St Bartholomew's Hospital for his
advice on the haematology of these
patients, Professor D. H. Wright (South-
ampton University) for reviewing Case 7,
Joan N. B. Edwards ofthe Virus Reference
Laboratory, Colindale for performing EBV
antibody tests, and Mrs L. Brown for
performing the cytochemical tests. The
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